Monday, June 15, 2026

Is Apple’s New AI System the Future of Smartphones?

Apple shares are skyrocketing early in the...

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Tag: Minho

No posts to display

Top News

- Our Sponsors Ad -

Follow us